1 Miura S, Tatsuguchi A, Wada K, Takeyamw H, Shinji Y, Hiratsuka T, et al.Cyclooxygenase-2-regulated vascular endo-thelial growth factor release in gastric fibroblasts[J]. Am J Physiol Gastrointest Liver Physiol, 2004;287:G444-51 2 Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al.COX-3, a cyclooxygenase-1variant inhibit-ed by acetaminophen and other analgesic antipyretic drugs:clon-ing, structure, and expression[J]. Proc Natl Acad Sci USA, 2002;99:13926-31 3 Roberts EG, Vona-Davis L, Riggs DR, Jackson BJ, Hohseni H, Kandzari ST, et al.COX-2 inhibition and cancer:experi-mental findings and clinical correlates[J]. W V Med J, 2004; 100:96-101 4 Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, et al.Cyclooxygenase-2 is expressed in neuroblasto-ma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo[J]. Cancer Res, 2004;64: 7210-5 5 Loudon JA, GroomKM, Bennett PR.Prostaglandin inhibitorsin preterm labour[J]. Best Pract Res ClinObstetGynaecol, 2003; 17:731-44 6 McGahan L.COX-2 inhibitors:a role in Alzheimer's disease [J]. Emerg Health Technol, 1999;10:1-6 7 Giovannini MG, Scali C, Prosperi C, Bellucci A, Pepen G, Casamenti F.Experimental brain inflammation and neurodegen-eration as model of Alzheimer'sdisease:protective effectsof se-lective COX-2 inhibitors[J]. Int J Immunopathol Pharmacol, 2003;16:31-40 8 Warner TD, Mitchell JA.Cyclooxygenase-3 (COX-3) :filling in the gaps toward a COX continuum[J]. Proc Natl Acad Sci USA, 2002;99:13371-3 9 Kis B, Snipes A, Bari F, Busija DW.Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system[J]. Brain Res Mol Brain Res, 2004;126:78-80 |